➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Johnson and Johnson
Mallinckrodt
Medtronic
Boehringer Ingelheim

Last Updated: April 21, 2021

DrugPatentWatch Database Preview

TERBUTALINE SULFATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Terbutaline Sulfate patents expire, and when can generic versions of Terbutaline Sulfate launch?

Terbutaline Sulfate is a drug marketed by Akorn, Athenex Inc, Dr Reddys, Fresenius Kabi Usa, Hikma Farmaceutica, United Biomedcl, Impax Labs, Lannett Co Inc, and Twi Pharms. and is included in nine NDAs.

The generic ingredient in TERBUTALINE SULFATE is terbutaline sulfate. There are seven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the terbutaline sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Terbutaline Sulfate

A generic version of TERBUTALINE SULFATE was approved as terbutaline sulfate by IMPAX LABS on June 26th, 2001.

  Start Trial

Drug patent expirations by year for TERBUTALINE SULFATE
Drug Prices for TERBUTALINE SULFATE

See drug prices for TERBUTALINE SULFATE

Recent Clinical Trials for TERBUTALINE SULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Mississippi Medical CenterN/A
American University of Beirut Medical CenterPhase 3

See all TERBUTALINE SULFATE clinical trials

Medical Subject Heading (MeSH) Categories for TERBUTALINE SULFATE

US Patents and Regulatory Information for TERBUTALINE SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn TERBUTALINE SULFATE terbutaline sulfate INJECTABLE;INJECTION 078151-001 Jan 7, 2008 AP RX No No   Start Trial   Start Trial   Start Trial
Impax Labs TERBUTALINE SULFATE terbutaline sulfate TABLET;ORAL 075877-001 Jun 26, 2001 AB RX No No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa TERBUTALINE SULFATE terbutaline sulfate INJECTABLE;INJECTION 076887-001 May 26, 2004 AP RX No No   Start Trial   Start Trial   Start Trial
Twi Pharms TERBUTALINE SULFATE terbutaline sulfate TABLET;ORAL 211832-002 Jun 19, 2020 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
McKesson
Moodys
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.